Ranade Eye Hospital Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-07-2024
- Paid Up Capital ₹ 1.00 M
as on 17-07-2024
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.89 Cr
as on 17-07-2024
- Satisfied Charges ₹ 4.21 Cr
as on 17-07-2024
- Revenue 16.22%
(FY 2023)
- Profit 10.64%
(FY 2023)
- Ebitda 1.20%
(FY 2023)
- Net Worth 38.77%
(FY 2023)
- Total Assets 0.34%
(FY 2023)
About Ranade Eye Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹5.89 Cr. The company has closed loans amounting to ₹4.21 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shashank Ranade and Mathangi Chari serve as directors at the Company.
- CIN/LLPIN
U74120MH2012PTC229726
- Company No.
229726
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 2012
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ranade Eye Hospital?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shashank Ranade  | Director | 16-Apr-2012 | Current |
| Mathangi Chari | Director | 16-Apr-2012 | Current |
Financial Performance of Ranade Eye Hospital.
Ranade Eye Hospital Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.22% increase. The company also saw a substantial improvement in profitability, with a 10.64% increase in profit. The company's net worth Soared by an impressive increase of 38.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ranade Eye Hospital?
In 2023, Ranade Eye Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ranade Opticals Private LimitedActive 7 years 1 monthShashank Ranade and Mathangi Chari are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 May 2021 | ₹1.70 Cr | Open |
Others Creation Date: 29 Jun 2018 | ₹4.19 Cr | Open |
Tjsb Sahakari Bank Limited Creation Date: 20 May 2017 | ₹3.70 Cr | Satisfied |
How Many Employees Work at Ranade Eye Hospital?
Unlock and access historical data on people associated with Ranade Eye Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ranade Eye Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ranade Eye Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
